Trials / Completed
CompletedNCT05579574
A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
An Open-Label, Single-Sequence, Crossover Study to Investigate the Interaction of Multiple Doses of BMS-986322 at Steady State and Multiple Doses of a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of multiple doses of BMS-986322 on the pharmacokinetics (PK) of Loestrin components in healthy female participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986322 | Specified dose on specified days |
| DRUG | Loestrin | Specified dose on specified days |
Timeline
- Start date
- 2022-10-21
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2022-10-14
- Last updated
- 2023-08-18
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05579574. Inclusion in this directory is not an endorsement.